Populations Publication Details



New Zealand Polynesians with Admixed History

Polymorphic Region:

1A*01:01 A*02:06 B*08:01 B*39:01 C*07:01 C*07:02 DRB1*03:01 DRB1*08:03
2A*02:01 A*24:02 B*40:01 B*56:02 C*01:02 C*03:04 DRB1*09:01 DRB1*09:01
3A*02:06 A*24:02 B*39:01 B*55:02 C*01:02 C*07:02 DRB1*09:01 DRB1*14:54
4A*02:01 A*24:02 B*15:06 B*44:02 C*04:03 C*15:02 DRB1*04:01 DRB1*15:02
5A*24:02 A*34:01 B*15:06 B*56:02 C*01:02 C*04:03 DRB1*04:03 DRB1*15:02
6A*02:01 A*34:01 B*15:01 B*40:02 C*01:02 C*15:02 DRB1*13:01 DRB1*14:08
7A*26:01 A*34:01 B*40:01 B*40:02 C*04:01 C*15:02 DRB1*04:03 DRB1*14:08
8A*01:01 A*24:02 B*55:02 B*57:01 C*01:02 C*06:02 DRB1*09:01 DRB1*15:01
9A*01:01 A*02:06 B*07:02 B*55:02 C*01:02 C*07:02 DRB1*12:01 DRB1*15:01
10A*02:01 A*24:02 B*40:01 B*40:01 C*03:04 C*03:04 DRB1*09:01 DRB1*09:01
11A*11:01 A*24:02 B*40:10 B*56:02 C*01:02 C*04:03 DRB1*04:05 DRB1*12:01
12A*24:02 A*34:01 B*40:01 B*56:01 C*03:04 C*07:02 DRB1*09:01 DRB1*09:01
13A*24:02 A*34:01 B*13:01 B*40:01 C*03:04 C*12:03 DRB1*04:05 DRB1*04:05
14A*34:01 A*34:01 B*40:02 B*40:02 C*15:02 C*15:02 DRB1*14:54 DRB1*14:54
15A*11:01 A*24:02 B*48:01 B*48:01 C*08:01 C*08:01 DRB1*08:03 DRB1*08:03
16A*02:06 A*24:02 B*40:01 B*55:02 C*01:02 C*03:04 DRB1*12:01 DRB1*13:02
17A*11:01 A*34:01 B*40:02 B*48:01 C*08:01 C*15:02 DRB1*08:02 DRB1*11:01
18A*24:02 A*34:01 B*56:02 B*56:02 C*01:02 C*01:02 DRB1*08:03 DRB1*09:01
19A*24:02 A*24:02 B*40:01 B*48:01 C*04:01 C*08:01 DRB1*04:03 DRB1*09:01
20A*11:01 A*34:01 B*13:01 B*40:10 C*04:03 C*12:03 DRB1*04:03 DRB1*04:05
21A*24:02 A*24:02 B*18:01 B*55:02 C*01:02 C*07:01 DRB1*09:01 DRB1*11:04
22A*02:06 A*24:02 B*40:10 B*56:02 C*01:02 C*04:03 DRB1*04:03 DRB1*11:01
23A*11:01 A*26:01 B*39:01 B*40:01 C*03:03 C*07:02 DRB1*14:54 DRB1*15:01
24A*02:01 A*11:01 B*27:05 B*40:01 C*01:02 C*04:03 DRB1*01:01 DRB1*04:03
25A*02:01 A*24:02 B*44:02 B*55:02 C*01:02 C*05:01 DRB1*12:01 DRB1*13:01
26A*11:01 A*34:01 B*13:01 B*40:01 C*04:03 C*12:03 DRB1*14:08 DRB1*15:02
27A*02:06 A*11:01 B*40:10 B*55:02 C*01:02 C*04:03 DRB1*08:03 DRB1*12:01

Allele frequency net 2015 update: new features for HLA epitopes, KIR and disease and HLA adverse drug reaction associations.
Gonzalez-Galarza FF, Takeshita LY, Santos EJ, Kempson F, Maia MH, Silva AL, Silva AL, Ghattaoraya GS, Alfirevic A, Jones AR and Middleton D Nucleic Acid Research 2015, 39, 28, D784-8.
Liverpool, U.K.


Valid XHTML 1.0 Transitional